Eversept Partners, LP
Top Portfolio Positions
110 positions ·
$1,817,420,308 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
264,271 | $156,707,417 | 8.62% | |
| QQQ |
Invesco Qqq Trust, Series 1
|
238,700 | $137,772,866 | 7.58% | |
| ABVX |
Abivax S.A.
Healthcare
|
934,423 | $104,048,001 | 5.73% | |
| GSK |
GSK plc
Healthcare
|
1,785,175 | $98,523,808 | 5.42% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
2,173,286 | $87,431,295 | 4.81% | |
| NTRA |
Natera, Inc.
Healthcare
|
384,713 | $76,938,752 | 4.23% | |
| SPY |
Spdr S&P 500 ETF Trust
|
107,000 | $69,586,380 | 3.83% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
2,885,622 | $67,408,129 | 3.71% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
1,788,016 | $56,715,867 | 3.12% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
924,193 | $53,704,855 | 2.96% |
Portfolio Trend
25 quarters · across all stocks
Holdings in NTRA
Shares Held
Position Value (USD)
20 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $76,938,752 | 384,713 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $76,629,001 | 334,493 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $83,647,094 | 519,644 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $134,539,592 | 796,375 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $126,381,086 | 893,721 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $138,792,057 | 876,766 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $110,471,001 | 870,193 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $127,077,665 | 1,173,494 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $162,620,544 | 1,778,051 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $141,039,472 | 2,251,588 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $110,299,143 | 2,492,636 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $117,454,875 | 2,413,787 | Shares | Sole | 2023-11-08 | |
| 2023-03-31 | $156,553,630 | 2,819,770 | Shares | Sole | 2023-11-08 | |
| 2022-12-31 | $107,894,973 | 2,685,959 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $62,469,879 | 1,425,602 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $16,857,213 | 475,655 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $9,532,410 | 102,071 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $12,502,342 | 112,189 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,057,418 | 9,314 | Shares | Sole | 2023-11-08 | |
| 2021-03-31 | $5,858,858 | 57,700 | Shares | Sole | 2021-05-13 | |
| No 13F history on record for this holder in this stock. | ||||||